E. Kalkhoven et al., SYNTHETIC PROGESTINS INDUCE PROLIFERATION OF BREAST-TUMOR CELL-LINES VIA THE PROGESTERONE OR ESTROGEN-RECEPTOR, Molecular and cellular endocrinology, 102(1-2), 1994, pp. 45-52
Proliferation of the human breast tumor cell lines T47D and MCF7 was s
timulated by high concentrations (10(-6) M) of the synthetic progestin
s gestodene and 3-ketodesogestrel, but not by Org2058, comparable to t
he stimulation by low dosages of estradiol (10(-10) M). At physiologic
al concentrations of the progestins (10(-10) M) only T47D cells respon
ded. Using specific antihormones it was shown that the effect at pharm
acological dosages is mediated by a crossreaction of these compounds w
ith the estrogen receptor (ER), while the stimulation of T47D cells at
physiological concentrations seems progesterone receptor (PR) mediate
d. This was further substantiated using transient transfection assays
with ER- and PR-inducible reporter constructs and mRNA induction of th
e ER- and PR-target genes pS2 and fatty acid synthetase, respectively.
Using a whole cell ligand binding assay, 20-fold higher amounts of PR
were measured in T47D compared to MCF7 cells. This was in line with a
much higher PR-dependent transactivation in T47D cells and suggests t
hat the level of transcriptionally active PR is a major determinant fo
r the response to physiological concentrations of progestins in human
breast cancer cells.